Arthritis & Rheumatism, Volume 62,
November 2010 Abstract Supplement
Abstracts of the American College of
Rheumatology/Association of Rheumatology Health Professionals
Annual Scientific Meeting
Atlanta, Georgia November 6-11, 2010.
Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor, Represses Fibrotic Changes in a Murine Model of Pulmonary Fibrosis.
Dactylitis in Psoriatic Arthritis (PsA): Prevalence and Response to Therapy in the Biologic Era.
Daily Electronic Reports of Pain and Activity Difficulties in Children with JIA Versus Children with Other Rheumatic Diseases.
DAS28 Level at Baseline Best Predicts Which Patients with New Onset Inflammatory Arthritis Will Ultimately Require Biologic Therapy.
DAS-Driven Therapy Versus Routine Care in Patients with Recent-Onset Active Rheumatoid Arthritis: Data from the GUEPAR Trial and ESPOIR Cohort.
DC-STAMP (Dendritic Cell-Specific Transmembrane protein), a Potential Biomarker To Predict the Risk of Psoriasis Patients in Developing Psoriatic Arthritis.
Decrease in Complement (C3) Levels during Systemic Lupus Erythematosus Pregnancy Is Associated with Higher Rates of Pre-Eclampsia.
Decreased Collagen Induced Arthritis (CIA) Severity in MAPK Kinase 6 Deficient Mice: Pivotal Role of Th1 and Th17 Cytokines.
Decreased Fibrin Clot Porosity in Patients with Antifosfolipid Syndrome.
Decreased Incidence of Synovitis, Osteitis, and Erosion in Early RA Patients Treated with Adalimumab Plus Methotrexate Compared to Those with Methotrexate Alone: High-Field MRI Analysis from OPTIMA.
Decreased Rate of Remission at 1 Year in Menopaused Women with Early Inflammatory Arthritis: The ESPOIR Cohort Study.
Decreased Recurrence Rate of Anterior Uveitis in Ankylosing Spondylitis Treated with AdalimumabAn Interim Analysis.
Decreased TH17 Cells in the Peripheral Blood of Patients with Early Spondyloarthritis (ESpA).
Decreased Vitamin D Levels in Children and Adolescents with Systemic Lupus Erythematosus.
Decreasing Fli1 Levels in Lupus T Cells Has Effects on Serum Immunoglobulin Levels and T Cell Infiltration in the Kidney.
Dectin-1 and NOD2 Mediate Zymosan-Induced Arthritis in Mice.
Defective ERK Signaling in Hematopoietic Progenitor Cells in Rheumatoid Arthritis.
Defective T Cell Tolerance in Rheumatoid Arthritis Due to Increased B-Raf and K-Ras Expression.
Deficiency in IFNHas Markedly Different Effects on Uveitis Versus Arthritis in the Aggrecan-Induced Mouse Model of Spondyloarthropathy.
Defining Latent and/or Disseminated Active Tuberculous Infection with TST, Quantiferon Gold and Multisite Cultures in TNFi Exposed Individuals.
Defining the Aromatase Inhibitor Musculoskeletal Syndrome: A Prospective Trial.
Demographic, Disease and Treatment Characteristics of the Rheumatoid Arthritis Population Enrolled in the AMORA Study (Applications for Methotrexate Optimization in Rheumatoid Arthritis) in Evaluating the Avise PGSM Test.
Demonstrating Musculoskeletal Ultrasound Competency in a Valid and Reliable Way.
Demonstration of the Structural Efficacy of Very Early DMARD Initiation in Early Inflammatory Arthritis in Clinical Practice: Results of a Propensity Analysis in the ESPOIR.
Demyelinating Events in Seniors with Rheumatoid Arthritis (RA): A Population-Based Study.
Dendritic Cell-Based Immunotherapy Combined with Low-Dose Methothrexate Is Effective in the Treatment of Advanced Collagen-Induced Arthritis in Mice.
Dendritic Cells and Continued Smoking in Rheumatoid Arthritis.
Dendritic Cells and Regulatory T CD4CD25Bright in Pregnant Patients with Systemic Lupus Erythematosus.
Dependence of IFN-Exaggerated Immunopathology and Clinical Disease on B Cells and BAFF in SLE-Prone NZM 2328 Mice.
Depression Rates Reported by Scleroderma (SSc) Patients Using Online Subject Recruitment and Questionnaire Completion. Feasibility of Data Collection Method and Comparison of Reported Depression Rates.
Depressive Symptoms and Perceived Communication around Shared Decision Making among Patients with Rheumatoid Arthritis.
Derivation of a Preliminary Administrative Claims-Based Algorithm To Identify Lack of Effectiveness of Rheumatoid Arthritis Medications.
Describing the Pattern of Outpatient Physical Therapy Utilization Following Total Knee Replacement (TKR).
Describing the Pattern of Physical Therapy Intervention Following Total Knee Replacement (TKR).
Describing the Performance of the Birmingham Vasculitis Activity Score (BVAS) at Diagnosis for Children with ANCA-Associated Vasculitis (AAV) in A Registry for Children with Vasculitis (ARChiVe).
Descriptive Epidemiology of Adult Rheumatoid Arthritis in an Insurance Claims Database.
Detection of HTLV-1 p19 Protein in Labial Salivary Glands from Patients with Sjgren's Syndrome: A Distinct Clinical Subgroup?
Detection of Potentially Disease Associated Copy Number Variants in Children with Rheumatoid Arthritis.
Detection of Radiographic Progression in Early Knee Osteoarthritis (CHECK): Sensitivity to Change of Knee Images Digital Analysis Compared to Altman Grading.
Detection of Specific Markers Using Proteomics: Our Research on the Marker in Patients with Kawasaki Disease (KD).
Determinants of Treatment Adherence in Patients with Systemic Lupus Erythematosus (SLE).
Determinants of Work Disability in Patients with Systemic Sclerosis: A Longitudinal Study of the GENISOS Cohort.
Determination of the Accurate Incidence of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis, Mixed Connective Tissue Disease and Systemic Lupus Erythematosus by Prospective Study for 3-Years.
Developing a Disease Activity and Therapeutic Response Index in Connective Tissue Disease Related Interstitial Lung Disease (CTD-ILD): Rationale, Aims, Design and Results from Tier 0, the Pre-Delphi Exercise.
Developing an Improved PROMIS Fatigue Short-Form for Use in Patients with Fibromyalgia.
Developing an Interactive Health Communication Application within Rheumatology: What Do Patients Want?
Development and Validation of a Questionnaire for Evaluation of Spondyloarthritis Related Manifestations in the First Degree Relatives of Patients with Ankylosing Spondylitis.
Development and Validation of an MRI Joint Space Narrowing Score for Use in Rheumatoid Arthritis: A Potential Adjunct to the OMERACT RA MRI Scoring System.
Development and Validation of the Brief-Satisfaction with Appearance Scale (Brief-SWAP) for Measuring Body Image in Systemic Sclerosis (SSc).
Development by the STPR Group of the Flare Instument, a New Tool To Identify Flare in Rheumatoid Arthritis (RA) in Clinical Practice.
Development of a Limited Scleroderma Cutaneous Activity and Damage Index.
Development of a Motivational Interviewing Protocol for Clinical Application in Osteoporosis.
Development of a Multi-Biomarker Test for Rheumatoid Arthritis (RA) Disease Activity (Vectra DA).
Development of a Vision Related Quality of Life Instrument for Children with Juvenile Idiopathic Arthritis-Associated Uveitis.
Development of an ACMGE Core Competency-Based Electronic Portfolio at the USC-LAC Rheumatology Fellowship Program.
Development of Classification Criteria for Polymyalgia Rheumatica (PMR): Results from an International, Prospective, Multi-Center Longitudinal Study ACREULAR Study Group for Development of Classification Criteria for PMR.
Development of Responder Definitions for Fibromyalgia Clinical Trials.
Development of the UK-Evaluation of Daily Activity Questionnaire (UK-EDAQ): Phase 2.
Diagnostic Accuracy of the 2010 ACR/EULAR Used at Baseline after a 10 Year Follow Up in a Cohort of Patients with Recent-Onset Arthritis.
Diagnostic Significance of Serum Interleukin-18 Level in Adult-Onset Still's Disease.
Diagnostic Value of Pathergy Phenomenon in Behcet's Disease.
Dietary Intake of Vitamin D during Adolescence and Risk of Adult Onset Systemic Lupus Erythematosus and Rheumatoid Arthritis.
Differences between PR3 and MPO-ANCA Associated Vasculitis Population Based Study from Southern Sweden.
Differences in Body Mass Index among Individuals with Psoriatic Arthritis, Psoriasis, Rheumatoid Arthritis, and the General Population.
Differences in Clinical and Economic Profiles of Rheumatoid Arthritis Patients Using Frequently Dosed Subcutaneous or Less Frequently Dosed Intravenous Biologic Therapy.
Differences in Disease Severity and Response to Biologic Agents in a Racially Diverse US-Based Cohort of Patients with Rheumatoid Arthritis (RA).
Differences in Muscle Strength and Pain Thresholds between Postmenopausal Women with and without RA.
Differences in the Autonomic Reactivity Pattern upon Various Stressors in Patients with Rheumatoid Arthritis.
Differences in the Observed Rate of Hip Fracture in Male and Female Patients Diagnosed with Osteoarthritis or Ankylosing Spondylitis Compared with the Expected Based on the General Population Seeking Health Care.
Differences in Transcription Profiles in Juvenile Idiopathic Arthritis (JIA) Patients Who Achieved Remission Using Different Therapies.
Different Diagnostic Criteria in the Diagnosis of Polymyalgia Rheumatica.
Different Factors Are Important for RA Patients and Rheumatologists Regarding DMARD Escalation.
Differential Association of IL23R Genetic Variants with Anti-CCP Positive and Negative Rheumatoid Arthritis Patients.
Differential Serum Glycosylation Changes in Rheumatoid and Psoriatic ArthritisIn Response to Anti-TNF Therapy.
Differentiation and Activation of Regulatory T-Lymphocytes in a TNF-alpha Transgenic Model of Arthritis, and the Impact of Passive or Active Anti-TNF Therapies.
Difficulty Using World Health Organization Criteria To Categorize Pulmonary Hypertension in Patients with Systemic Sclerosis.
Diffuse Calcium-Containing Crystal Deposits in Human Osteoarthritic Articular Cartilage: Not Limited to the Medial Compartment.
Dipyridamole Inhibits SLE T Cell Activation and Alleviates Nephritis in Lupus-Prone Mice.
Direct and Indirect Costs of Spondlyoarthritis Patients Pre- and Post-Diagnosis.
Direct Imaging Evidence That Adalimumab Induces Resolution of Inflammatory Lesions in AS Patients at Sites of Complete Spinal Ankylosis.
Disability and Knee Osteoarthritis: Associations with Individual and Community Socioeconomic Status.
Disappointing Responsiveness of the SF-6D to Improvement in Patients Receiving a First TNF-Blocker: Results of the DREAM Registry.
Disconnect between Radiographic Progression and Clinical Outcomes in Psoriatic Arthritis Patients Treated with Adalimumab.
Discontinuation of TNF-Inhibitor Treatment in Clinical Practice Has a Negative Impact on Radiographic Progression 2 Years after Initiation of Therapy. Results from the Nationwide Danish DANBIO Registry.
Discordance between Self-Report and Physician-Assessed Disease Activity in Patients with Systemic Lupus Erythematosus (SLE): Implications for Clinical Trial Design and Clinical Care.
Discovery and Replication of JIA Predisposition Genes by Genome-Wide Association and Validation of Candidates in Fibroblast-Like Synoviocytes.
Discriminative Power of Different Combinations of Bones and Joints for Assessing Change in Rheumatoid Arthritis with MRI: Results Based on Pooled Data from Four Multisite Clinical Trials.
Disease Activity Assessment by ASDAS Doesn't Predict Sacroiliac Inflammation with MRI in Axial SpA.
Disease Activity Assessment in Large Vessel Vasculitis.
Disease Activity in Patients with Early Rheumatoid Arthritis Receiving Stable Conventional DMARDs Significantly Influences the Timing of Achieving a Low Disease State and Remission at 3 Versus 6 Months.
Disease Activity, Calendar Year, and Physician Preference Are Associated with Switching of Biologic Agents for Reasons of Inadequate Efficacy.
Disease Activity, Proteinuria, and Vitamin D Status in Children with Systemic Lupus Erythematosus and Juvenile Dermatomyositis.
Disease Assessment in Takayasu's Arteritis: Data from a Literature Search and a Survey of Expert Opinion.
Disease Modifying Activity of Celecoxib on Articular Cartilage in Osteoarthritis?A Randomized Clinical Trial.
Disease Specific Cardiovascular Risk Factors in Patients with Rheumatic Diseases.
Diseases Associated with Positive NOD2/CARD15 Gene Mutations: Blau's Syndrome Versus an Intermediate Subset of Blau's Syndrome and Crohn's Disease.
Distinctions in the ISN/RPS 2003 Subclasses of Class IV Lupus Nephritis.
Distinctive Patterns of Gene Expression Post-Infliximab Therapy in Psoriasis, Rheumatoid and Psoriatic Arthritis.
Distinguishing Levels of Disease Flare in Patients with Systemic Lupus Erythematosus Using Administrative Claims Data.
DMARD Use for Rheumatoid Arthritis as Reported in the National Ambulatory Medical Care Survey, 19962007.
DMARD Use in Rheumatoid Arthritis: An Analysis of HEDIS Data from 20052008.
DNA Damage, T Cell Lymphopenia and Immunosenescence in Rheumatoid Arthritis.
DNA Hypomethylation Upregulates CXCL12 in Rheumatoid Arthritis Synovial Fibroblasts.
DNA Methylation Affects Gene Expression in CD4CD28- T Cells through microRNAs.
Do Bony Enlargements Correlate with Radiological Findings in Hand Osteoarthritis (HOA)?
Do Men and Women Cope Differently with Disease Impact of Rheumatoid Arthritis, and If So, Why?
Do Patients with Psoriatic Arthritis Who Present Early Fare Better Than Those Presenting Later in the Disease?
Do Patients with Rheumatoid Arthritis Exhibit Differential Cellular Responses to Implant Wear Debris and Do the Implant Failure Mechanisms Differ from Non-RA Patients?
Do Structural Damage and Inflammation Impact Physical Functioning Differently Based on Duration of Rheumatoid Arthritis?
Do the New EULAR/ACR Rheumatoid Arthritis Classification Criteria Identify Early Psoriatic Arthritis Patients?
Does an RA Peer Support Program Impact Disease Outcomes?
Does Asymptomatic Hyperuricemia Treatment Improve Health? A Decision-Analytic Evaluation.
Does Atorvastatin Reduce Progression of Carotid Intimal Medial Thickening (CIMT) in Childhood SLE? Results from the Atherosclerosis Prevention in Pediatric Lupus (APPLE) Trial: A Multicenter, Randomized, Double-Blind Placebo-Controlled Study.
Does Cigarette Smoking Affect Disease Phenotype in Systemic Lupus Erythematosus.
Does Obesity in Patients with Fibromyalgia Modify Response to Tai Chi Therapy: Analysis of a Randomized Controlled Trial.
Does Physical Activity Dose Predict Physical and Mental Health-Related Quality of Life in People with Arthritis?
Does Sequence Matter When Switching from One AntiTumor Necrosis Factor Agent to Another?
Does Smoking Influence Disease Manifestations and Disease Severity in Systemic Lupus Erythematosus?
Does Treatment with Imatinib Modify Gene Expression in the Skin and Peripheral Blood Mononuclear Cells of Patient with Systemic Sclerosis?
Dorsal Root Ganglia/Sympathetic Ganglia Sodium Channels Gene Polymorphisms in Fibromyalgia.
Dose Matters: The Risk of Complicated Gastroduodenal Ulcers with Naproxen Is Dose-Dependent.
Dosing of Anti-Tumor Necrosis Factor Biologics (Anti-TNFs) for Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA) in Clinical Practice in the United States.
Double-Blind, Randomized, Controlled, Placebo-Included, Pilot Study Comparing Classical Ayurvedic Medicine, Methotrexate, and Their Combination in RA.
Down-Regulated MicroRNA-152 Induces Aberrant DNA Methylation in Scleroderma Endothelial Cells by Targeting DNA Methyltransferase 1.
Down-Regulation of Pyrin Promotes Up-Regulation of the Anti-Apoptotic Gene, BCL2, Via the Signal Transducer, gp130, and Leads to the Activation of the PI3K/Akt Pathway.
Downregulation of the Chemokine Receptor CX3CR1 in Active RA Associated with a Pro-Osteoclastognic Phenotype.
Downstream Targets of IL-17 in Rheumatoid Arthritis.
Drug Free REmission after Cessation of Tocilizumab (Actemra) Monotherapy (DREAM Study).
Dual Roles of Heme Oxygenase-1 on Rheumatoid Arthritis: Anti-Inflammation Versus Angiogenesis.
Durability of Clinical Remission in Rheumatoid Arthritis Based on Various Criteria.
Durability of Response in a 38-Week Open-Label Study of Sodium Oxybate in Patients with Fibromyalgia.
DXA Screening and Use of Osteoporosis Medications in Two Large Regional Healthcare Systems.
Dysfunction of Hematopoietic Stem Cells in Lupus Mice.
Dysfunctional, Pro-Inflammatory High Density Lipoproteins Directly Influence Monocyte PDGFR Transcript Levels, TNF Secretion, and Chemotaxis.
Dyspnea in Scleroderma Patients from the PHAROS Registry: A Major Contributor to Disability.
Dys-Regulation of T-Cell Subsets and Cytokines Is Associated with the Development of Inflammatory Symptoms in ACPA-Positive Asymptomatic Individual.
Dysregulation of the Microvascular as Assessed by Expression of Protective and Injury Associated Markers Is Reflected in the Non-Lesional Non-Sunexposed Skin of Patients with Lupus Nephritis.